US Dollar vs Yen

登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。

ホーム
投資
株式
カナダ
TSX
BELLUS Health Inc (BLU)
BELLUS Health Inc (BLU) ニュース

BELLUS Health Inc (BLU)

19.48

0.00

(0.00%)

終了 7月3日 5:12AM

個人投資家向けのプロ仕様のツール。

プレミアム

Energy Explorer Lands Strategic Offshore Asset with Historic Production Data

The offshore oil and gas sector continues to draw attention as companies revisit legacy discoveries with modern technology and improved economics...

Annonce boursière - Réservée aux médias et aux investisseurs - GSK mène à terme l'acquisition de BELLUS Santé

Annonce boursière - Réservée aux médias et aux investisseurs - GSK mène à terme l'acquisition de BELLUS...

Stock-exchange announcement - For media and investors only - GSK completes acquisition of BELLUS Health

Stock-exchange announcement - For media and investors only - GSK completes acquisition of BELLUS Health Canada NewsWire LONDON, June 28, 2023...

S&P Dow Jones Indices annonce des modifications à l'indice composé S&P/TSX et à l'indice S&P/TSX 60

S&P Dow Jones Indices annonce des modifications à l'indice composé S&P/TSX et à l'indice S&P/TSX 60 Canada...

S&P Dow Jones Indices Announces Changes to the S&P/TSX Composite Index and S&P/TSX 60 Index

S&P Dow Jones Indices Announces Changes to the S&P/TSX Composite Index and S&P/TSX 60 Index Canada NewsWire TORONTO, Sept. 2, 2022...

BELLUS Health to Present Late-Breaking Clinical Data from the Phase 2b SOOTHE Trial of BLU-5937 at the ATS 2022 International Conference

BELLUS Health Inc. (Nasdaq:BLU; TSX:BLU) (“BELLUS Health” or the “Company”), a clinical-stage biopharmaceutical company developing novel...

BELLUS Santé participera prochainement à plusieurs conférences pour les investisseurs

BELLUS Santé inc. (Nasdaq : BLU; TSX : BLU) (« BELLUS Santé » ou la « société »), une société biopharmaceutique au stade clinique qui développe...

BELLUS Santé participera à la Cowen & Co. 42nd Annual Health Care Conference

BELLUS Santé inc. (Nasdaq : BLU; TSX : BLU) (« BELLUS Santé » ou la « société »), une société biopharmaceutique au stade clinique qui développe...

BELLUS Santé annonce ses résultats financiers et faits saillants pour l’exercice 2021

- Annonce des résultats principaux positifs de l’essai clinique SOOTHE de phase 2b pour le traitement de la toux chronique réfractaire qui...

BELLUS Health Closes US$200 Million Public Offering of Common Shares in Canada and the United States

BELLUS Health Inc. (NASDAQ: BLU)(TSX: BLU) (the “Company” or “BELLUS Health”) announced today that it has completed its previously-announced...

mik1234

mik1234 6年前

it was a good day $$ BLU

Oliverjack

Oliverjack 6年前

insider bought 260k worth today monday 13th lol

Bottom Feedr

Bottom Feedr 6年前

Massive drop and ceo buys more! Hmmnnnn

Bottom Feedr

Bottom Feedr 6年前

Wake up sleepy head time to rock the market!

dalesio_98

dalesio_98 7年前

RichardSawars

RichardSawars 7年前

TrendTrade2016

TrendTrade2016 8年前

BLU.TO hot canadian bio

TrendTrade2016

TrendTrade2016 8年前

BLU is a beast!!

TrendTrade2016

TrendTrade2016 8年前

The BLU beast!!

TrendTrade2016

TrendTrade2016 8年前

put out a call on BLU.TO a monster bio play!!

xr_biotech_consult

xr_biotech_consult 10年前

happy to sold nearly 8000 during last days...only 4000 left for sale today.

xr_biotech_consult

xr_biotech_consult 10年前

2.99 weeeeEEEE°°

xr_biotech_consult

xr_biotech_consult 10年前

what shoud i say? 2.32 !!

xr_biotech_consult

xr_biotech_consult 10年前

xr_biotech_consult

xr_biotech_consult 10年前

yessss..new high..1.92

xr_biotech_consult

xr_biotech_consult 10年前

great Chart.. crushed 1,75 good sign. more will come

xr_biotech_consult

xr_biotech_consult 10年前

pivotal Phase 3 trail completed, top line results expected q2, fast track by FDA, rare desease, Long patent protection, Peak sales expected -1b ! ongoing Pipeline with rare deseases.. still great opportunity here

xr_biotech_consult

xr_biotech_consult 10年前

xr_biotech_consult

xr_biotech_consult 10年前

hrhr here weee goo

xr_biotech_consult

xr_biotech_consult 10年前

expected Prices per Patient per year 200-275 Thousand

xr_biotech_consult

xr_biotech_consult 10年前

Peak sales expected 600m - 1b
http://www.bellushealth.com/English/investors-and-news/presentations/default.aspx

xr_biotech_consult

xr_biotech_consult 10年前

xr_biotech_consult

xr_biotech_consult 11年前

will move up again

xr_biotech_consult

xr_biotech_consult 12年前

target 2.50 CAD

xr_biotech_consult

xr_biotech_consult 12年前

yea hell great, new high hunts new high

xr_biotech_consult

xr_biotech_consult 12年前

BLU out in the blue

xr_biotech_consult

xr_biotech_consult 12年前

waht did i told u

xr_biotech_consult

xr_biotech_consult 12年前

massive breakout will come here

Alicanto Minerals

Tribeca Global Natural R...

MetalsGrove Mining

Austco Healthcare

Cauldron Energy

Adavale Resources

Target Maturity Sept 202...

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

ADVFN

すでにアカウントをお持ちですか？サインイン

アカウントをお持ちでないですか？登録

登録することで、ADVFN の利用規約を読み、理解し、同意したこと、および私が個人投資家であることを確認します。